Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Clinical trial NCT04541212 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04541212
- Sponsor
- Montreal Heart Institute
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-02
- Primary completion
- 2027-04-30
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.